Servier
22 Rue Garnier
Neuilly Sur Seine
92200
France
Website: http://www.servier.com/
Email: webmaster@servier.com
190 articles about Servier
-
miRagen Therapeutics Scores $352 Million Cardio microRNA Development Deal With Servier
10/18/2011
-
Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields
10/10/2011
-
Servier Signs Cancer Pact with Galapagos NV for Up to €260 Million
10/3/2011
-
Servier Founder Ensnared in Mediator Scandal; Charged in Deaths and Granted 4 Million Euro Bail
9/22/2011
-
Servier Faces Another Scandal Over Another Drug
9/9/2011
-
Intercept Pharmaceuticals, Servier Announce up to $163 Million Agreement for Intercept's TGR5 Research Program in Type 2 Diabetes
8/9/2011
-
Cortex Pharmaceuticals, Inc. Enters into New Agreement with Servier; Cortex Could Possibly Receive $3 Million
6/13/2011
-
Servier Denies French Allegation of Concealing Mediator Diabetes Drug Risk
5/9/2011
-
Pharmacyclics, Inc. Achieves $7 Million Development Milestone for HDAC Inhibitor, PCI-24781/S 78454 with Servier
4/26/2011
-
Galapagos NV Receives EUR4 Million in Milestones from Servier
2/8/2011
-
Galapagos NV Receives EUR4 Million in Milestones from Servier
2/8/2011
-
XOMA (US) LLC and Servier Sign Pact for Top Diabetes Drug Candidate; XOMA Could Receive up to $505M
1/4/2011
-
Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths
11/16/2010
-
Vernalis PLC and Servier Achieve Research Milestone in 2nd Oncology Collaboration
10/6/2010
-
Osteologix Inc. and Servier Announce Ex-US Licensing Agreement
8/2/2010
-
Servier And Galapagos NV Initiate Strategic Alliance In Osteoarthritis
7/1/2010
-
Servier Collaborates with Shanghai Institute of Materia Medica on Cancer Drug Discovery
10/15/2009
-
Servier Release: Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Euro
2/24/2009
-
Servier: First Head-To-Head Study Shows That Protelos(R) (Strontium Ranelate) Builds Better Bone Than Bisphosphonate
12/8/2008
-
Drugmakers Servier and Teva Pharmaceutical Industries Limited Targeted in EU Raids
11/26/2008